The FDA Law Blog

MARCH 5, 2024

Many individual states have pursued some type of legislation to restrict the use of traditional meat terminology for the labeling of APPs. Many states have proposed but failed to enact legislation regulating the labeling of APPs, in some cases due to concerns of potential legal challenges based on federal preemption claims.

Labelling 59

Labelling FDA 59

The FDA Law Blog

APRIL 25, 2024

Promotional labeling is generally any labeling other than FDA-required labeling that is devised for the promotion of a product, as well as other functions, and can include printed, audio, or visual matter that describes the product. l)(1) (e.g.,

Labelling 59

Labelling Communication FDA 59

The FDA Law Blog

AUGUST 23, 2022

By doing so, FDA has limited the number of tests that have reached the market, thereby reducing available supply and increasing prices. As FDA would acknowledge, the antigen tests are the fastest and most practical method for distributing testing in the general population. That could happen again.

Labelling 97

Labelling Communication FDA Medical Schools 97

The FDA Law Blog

OCTOBER 5, 2022

By Riëtte van Laack — On September 28, 2022, FDA announced the availability of the proposed rule for the implied nutrient content claim “healthy.” The term healthy, as an implied nutrient claim, was first defined by FDA in 1994. FDA also announced it would be re-evaluating the regulatory criteria for use of the “healthy” claim.

FDA 52

FDA Labelling Packaging Documentation 52

The FDA Law Blog

SEPTEMBER 22, 2024

The webinar largely consisted of summarizing the general requirements under Parts 803, 806 and 820.198, which we do not reproduce here ( but see another of our prior blog posts discussing these requirements and their applicable to LDTs in greater detail; you can also find FDA’s slides from the webinar here ).

FDA 64

FDA Communication Labelling 64

Pharmaceutical Technology

SEPTEMBER 5, 2022

The US Food and Drug Administration (FDA) has approved the expanded usage of Vertex Pharmaceuticals ’ Orkambi (lumacaftor/ivacaftor) to treat cystic fibrosis (CF) in children aged 12 months to under 24 months. Earlier, the therapy had obtained FDA approval for usage in CF patients aged two years and above with two F508del mutation copies.

FDA 52

FDA Labelling 52

The FDA Law Blog

OCTOBER 10, 2022

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. While the final guidance includes the same definition of “signal” as that used in the draft guidance—i.e., Karst & Steven J.

FDA 52

FDA Labelling Documentation Communication 52

The FDA Law Blog

FEBRUARY 22, 2023

Shapiro — More than a decade ago, FDA began systematically to incorporate review of human factors (HF) design validation within 510(k) reviews. Now FDA has issued a draft guidance , Content of Human Factors Information in Medical Device Marketing Submissions (Dec. FDA did not require HF data as a basis for clearance of the predicate.

FDA 64

FDA Documentation Labelling Hospitals 64

European Pharmaceutical Review

JULY 4, 2024

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few?

FDA 103

FDA Documentation Compounding Pharmaceutical Companies 103

The FDA Law Blog

JUNE 12, 2023

By Riëtte van Laack — FDA regulates pet food similar to other animal foods. The Federal Food, Drug, and Cosmetic Act (FDC Act) requires that all animal foods, like human foods, be safe to eat, produced under sanitary conditions, contain no harmful substances, and be truthfully labeled.

Labelling 45

Labelling FDA Packaging 45

The FDA Law Blog

AUGUST 4, 2023

DASCA amended the CSA by revising and adding specified substances to the definition of “anabolic steroid,” providing for the temporary and permanent scheduling of anabolic steroids and adding labeling requirements for products containing anabolic steroids. Implementation of the Designer Anabolic Steroid Control Act of 2014 , 88 Fed.

Controlled Substances 52

Controlled Substances Labelling 52

The FDA Law Blog

OCTOBER 26, 2022

Walsh — The question of whether FDA has authority to take pictures during an inspection of a facility has bounced around the food and drug bar for many years. FDA’s view is stated in the agency’s Investigation Operations Manual, and it is one with which a number of practitioners disagree. By Ricardo Carvajal & Anne K.

FDA 59

FDA Labelling Documentation 59

The Checkup by Singlecare

MARCH 12, 2024

What’s considered “normal” bowel movements and the definition of constipation and diarrhea differs from patient to patient, so the definition of alleviating those concerns varies as well. That’s for good reason, says Rishi Naik, MD, MSCI , gastroenterologist and assistant professor of medicine at Vanderbilt University Medical Center.

Hospitals 105

Hospitals Dosage Labelling FDA 105

The FDA Law Blog

MAY 15, 2023

At the federal level, the Center of Veterinary Medicine (CVM) of FDA regulates food for animals, including livestock and pets. States frequently review labels (and labeling) for animal food products. AAFCO’s ingredient definitions are not federal regulations and do not have the force or effect of federal law.

Labelling 45

Labelling Documentation FDA 45

Pharmaceutical Technology

JUNE 21, 2023

Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. Ketamine is currently on the FDA’s drug shortage list. Ketarx will then be commercially launched in the second quarter.

Hospitals 52

Hospitals FDA Dosage Labelling 52

Pharmaceutical Technology

JANUARY 19, 2023

Sun Pharmaceutical Industries has signed a definitive agreement to buy all outstanding shares of Concert Pharmaceuticals, in a deal valued at $576m. It is currently being evaluated in two open label, long-term extension trials in North America and Europe. per share in cash upfront payment. per share of common stock in cash.

Labelling 59

Labelling FDA 59

The FDA Law Blog

OCTOBER 6, 2023

Javitt & Philip Won — As we reported last week, FDA has issued a 26 page, single spaced, tiny-font Proposed Rule of Laboratory Developed Tests (LDTs). Change to the IVD definition First, the mechanics of the change. It does not extend to tests for which FDA has historically not exercised enforcement discretion (e.g.,

FDA 64

FDA Labelling 64

The FDA Law Blog

FEBRUARY 14, 2023

Gaulkin & Riëtte van Laack — Chocolate-lovers and hopeless romantics rejoice: FDA has announced that it does not intend to object to the use of certain qualified health claims regarding the relationship between the consumption of cocoa flavanols in high flavanol cocoa powder and a reduced risk of cardiovascular disease. By Sophia R.

FDA 40

FDA Labelling 40

The Checkup by Singlecare

JANUARY 23, 2024

There are no medications with a Food and Drug Administration (FDA) approved indication for muscle relaxation available over the counter in the United States. There is one OTC drug product that is sometimes used off-label (without FDA approval) as a muscle relaxant, and that is guaifenesin. Dantrolene acts directly on the muscle.

FDA 105

FDA Labelling 105

The Checkup by Singlecare

SEPTEMBER 25, 2023

Things are a little less definitive when talking about children. Follow the proper label instructions for each. Canadian Family Physician (2012) Maxigesic Rapid® tablets gain US FDA approval. Sources: Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial.

Mayo Clinic 111

Mayo Clinic Dosage Labelling FDA 111

The FDA Law Blog

OCTOBER 11, 2022

Valentine — As we begin the final quarter of 2022 and the leaves here on the east coast begin to turn and fall, it seems the clock may be running out on FDA and the Center for Drug Evaluation and Research (CDER) to meet its goal of publishing a draft guidance on confirmatory evidence this year. Sasinowski & James E.

FDA 61

FDA Documentation Labelling 61

The Checkup by Singlecare

FEBRUARY 8, 2024

Food and Drug Administration (FDA) advisory committee met to discuss evidence suggesting that oral phenylephrine, one of the active ingredients found in most over-the-counter decongestants, is ineffective for relieving nasal congestion. However, the FDA has not yet arrived at a definite conclusion as the evidence is still under review.

Medication Labelling 98

Medication Labelling FDA Packaging Labelling 98

The FDA Law Blog

OCTOBER 2, 2023

Sasinowski — This time last year, we wrote about a long-overlooked FDA statutory authority and wondered if this provision, known colloquially as the “single study plus confirmatory evidence” pathway, was having a moment (previous post here ). Valentine & Frank J.

FDA 64

FDA Documentation Labelling Medical Records 64

The Checkup by Singlecare

APRIL 14, 2023

But just because it was done in the past doesn’t make it safe; today’s experts generally recommend avoiding the use of Adderall for weight loss, not only because it’s not effective for this purpose but because it comes with some definite risks. Here’s what you need to know. Does Adderall make you lose weight?

Controlled Substances 98

Controlled Substances Dosage Labelling FDA 98

The Checkup by Singlecare

OCTOBER 23, 2024

It is approved by the Food and Drug Administration (FDA) to treat plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. The FDA classifies drugs used in pregnancy into one of five categories: A, B, C, D, and X. Actemra also lacks the data to definitely confirm safety.

Medication Guidelines 52

Medication Guidelines FDA Labelling Immunization 52

The FDA Law Blog

NOVEMBER 2, 2023

Lewis, Senior Regulatory Device & Biologics Expert — On October 20, 2023, FDA announced the availability of the final guidance authored by CBER titled “Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies.” Tobolowsky & Richard A. It finalized a draft guidance published in 2022.

FDA 59

FDA Packaging Documentation Communication 59

The FDA Law Blog

MAY 19, 2023

Collection Device Special Controls Sponsor will need to select a collection device that is either FDA-cleared, -approved, or -classified as 510(k) exempt (either as a standalone collection device or as part of a system) or alternatively the collection device can be cleared within the premarket submission for the POC test.

Labelling 40

Labelling FDA Documentation 40

The Checkup by Singlecare

NOVEMBER 5, 2024

Approved by the Food and Drug Administration ( FDA ) in 1992 for short-term treatment of insomnia, it has subsequently become available in a generic form. Annually, the expense would add up to over $9000, but according to its label , Ambien is only meant for short-term use, with a time frame of 4 to 5 weeks mentioned in the label.

Insurance 52

Insurance Labelling Insurance Coverage Controlled Substances 52

The Checkup by Singlecare

MARCH 20, 2024

Metformin is an FDA-approved drug for the treatment of Type 2 diabetes. Although metformin is only approved for use in treating Type 2 diabetes, it has several off-label uses, including as a treatment for polycystic ovary syndrome (PCOS), gestational diabetes, and drug-induced weight gain.

Labelling 105

Labelling FDA 105

The FDA Law Blog

JUNE 28, 2023

The proposed legislation appears to be an effort to resolve issues created by FDA’s Center for Veterinary Medicine’s (CVM) interpretation of the Federal Food, Drug, and Cosmetic Act (FDC Act) definition of food.

Labelling 45

Labelling FDA 45

The Checkup by Singlecare

JANUARY 13, 2023

According to the drug’s FDA label , there is no known clindamycin and alcohol interaction. You definitely will want to avoid a night of binge drinking while on clindamycin. However, some antibiotics, such as clindamycin, may be safer than others when mixed with alcohol.

Adverse Reactions 98

Adverse Reactions Dosage Immunization Labelling 98

The Checkup by Singlecare

FEBRUARY 11, 2025

Food and Drug Administration (FDA) to treat Type 2 diabetes mellitus and lower the risk of heart attack or stroke in people with Type 2 diabetes and cardiovascular disease. Healthcare providers may also use Ozempic injectables off-label for weight loss management. Ozempic (semaglutide) is an injectable medication approved by the U.S.

FDA 69

FDA Dosage Labelling 69

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

The FDA Law Blog

AUGUST 17, 2022

Koblitz — After 5 long years, FDA has finally adopted the long-awaited OTC hearing aid rules. Kudos to FDA for getting this out so quickly and even making some significant changes and clarifications in response to the comments it received on the Proposed Rule. This was especially a concern in the context of self-fitting hearing aids.

FDA 40

FDA Labelling 40

DiversifyRx

JULY 11, 2024

Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. If the FDA or another regulator requests DSCSA transaction data, the DSCSA regulations give you up to 48 hours to respond. The original article can be found HERE.

Independent Pharmacies 52

Independent Pharmacies FDA Documentation CPhT 52

The FDA Law Blog

FEBRUARY 27, 2023

The Act also established new definitions for “Internet,” “online pharmacy,” “practice of telemedicine,” among others. Comment topics suggested by DEA include the following: Whether the rule should limit the issuance of prescriptions for controlled medications to FDA-approved indications contained in the labeling for those medications.

Controlled Substances 59

Controlled Substances FDA Documentation Communication 59

The Thyroid Pharmacist

OCTOBER 7, 2022

Sure enough, she read all the labels on her supplements and in her pantry, and gave her kitchen a stevia-free makeover. Steviol glycosides, which are refined extracts of stevia, are recognized as safe by the Food and Drug Administration (FDA). 13,16,18) Given this, stevia definitely seems to be a better alternative to sugar!

Immunization 98

Immunization Labelling Compounding FDA 98